Literature DB >> 22819280

Squamous-cell carcinoma of the lungs: is it really so different?

María Sereno1, Isabel Rodríguez Esteban, Francisco Zambrana, María Merino, César Gómez-Raposo, Miriam López-Gómez, Enrique Casado Sáenz.   

Abstract

BACKGROUND: Squamous cell carcinoma (SCC) is the predominant histological type in men, and adenocarcinoma is the most common subtype in women in the world. The incidence of SCC is decreasing in men, while the incidence of adenocarcinoma (AC) is stable or slightly increasing in western countries. There is active research on the AC subtype but SCC remains poorly studied.
CONCLUSIONS: In this review, we have studied different aspects of the SCC subtype, including epidemiology, clinical features, pathology, molecular biology markers, and new therapeutic targets, treatments and prognosis implications.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22819280     DOI: 10.1016/j.critrevonc.2012.06.009

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  5 in total

1.  Potential Role of S100A8 in Cutaneous Squamous Cell Carcinoma Differentiation.

Authors:  Jung-Min Shin; In-Kyu Chang; Young-Ho Lee; Min-Kyung Yeo; Jin-Man Kim; Kyung-Cheol Sohn; Myung Im; Young-Joon Seo; Chang-Deok Kim; Jeung-Hoon Lee; Young Lee
Journal:  Ann Dermatol       Date:  2016-03-31       Impact factor: 1.444

2.  Factors leading to the risk of stroke mortality: a cross-sectional study with lung cancer patient-based large sample.

Authors:  Lei Chen; Xinmin Zhao; Sheng Wang
Journal:  Eur J Cancer Prev       Date:  2022-01-01       Impact factor: 2.164

3.  Identification and Validation of Prognostic Markers for Lung Squamous Cell Carcinoma Associated with Chronic Obstructive Pulmonary Disease.

Authors:  Zheng Li; Dan Xu; Jing Jing; Jing Wang; Min Jiang; Fengsen Li
Journal:  J Oncol       Date:  2022-08-17       Impact factor: 4.501

4.  Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma.

Authors:  Rie Matsuwaki; Genichiro Ishii; Yoshitaka Zenke; Shinya Neri; Keiju Aokage; Tomoyuki Hishida; Junji Yoshida; Satoshi Fujii; Haruhiko Kondo; Tomoyuki Goya; Kanji Nagai; Atsushi Ochiai
Journal:  Cancer Sci       Date:  2014-07-01       Impact factor: 6.716

5.  The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma.

Authors:  Zhi-Hong Jian; Jing-Yang Huang; Frank Cheau-Feng Lin; Oswald Ndi Nfor; Kai-Ming Jhang; Wen-Yuan Ku; Chien-Chang Ho; Chia-Chi Lung; Hui-Hsien Pan; Yu-Chiu Liang; Ming-Fang Wu; Yung-Po Liaw
Journal:  BMC Pulm Med       Date:  2015-12-03       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.